GulfLINK banner
Site Map | Search | Contact Us
LIBRARY
  Overview
Case Narratives
Environmental Exposure Reports
Information Papers
RAND Reports
NEWS ARCHIVE
  Overview
Press Releases
Speeches
HELP FOR VETERANS
  Overview
Medical Information
Medals
The 1990-1991 Gulf War Story
Related Sites
FAQS
  Overview
Depleted Uranium
Khamisiyah
Pyridostigmine Bromide

Serial Corticotropin-Releasing Hormone Levels and Adrenocortical Activity in Combat Veterans with Posttraumatic Stress Disorder

D.G. Baker1,2 , S.A. West2, W.E. Nicholson3, N.N. Ekhator1,2, J.W. Kasckow1,2
K.K. Hill1, A.B. Bruce1, E.C. Somoza1,2, D.N. Orth3, T.D. Geracioti1,2

From the Psychiatry Service, Cincinnati Veterans Affairs Medical Center1 and the Department of Psychiatry, University of Cincinnati College of Medicine2 and the Department of Medicine3, Vanderbilt University Medical Center, Nashville, TN

Objective: We sought to carefully test the hypothesis that basal cerebrospinal fluid (CSF) corticotropin releasing hormone (CRH) hyperactivity exists in patients with posttraumatic stress disorder (PTSD) by using a technique of continuous CSF sampling. We also sought to assess the relationship between PTSD symptoms, adrenocortical activity and CSF CRH.

Methods: We withdrew CSF via a flexible, indwelling subarachnoid catheter over a six-h period and determined hourly CSF concentrations of CRH in 11 well characterized combat veterans with PTSD and 12 matched normal volunteers. Urine was obtained for urinary free cortisol (UFC) determination. PTSD and depressive symptoms were correlated with the neuroendocrine data.

Results: Mean CSF CRH was significantly greater in PTSD patients compared with controls (55.19 + 16.42 pg/ml v.s. 42.24 + 15.60 pg/ml, [F(1,18)= 6.04, p< .05]). A significant positive correlation was observed between CSF CRH concentrations and depressive symptoms (r = .63, df =9, p =.05) but not between CSF CRH concentrations and PTSD symptoms. While there were no significant differences between groups in 24-h UFC concentrations, the correlation between 24h UFC concentrations and PTSD symptoms (r = -.72, df = 9, p < .02) was negative and significant.

Conclusions: Using a serial CSF sampling technique, we found high basal CSF CRH concentrations and normal 24-h urinary free cortisol excretion in combat veterans with PTSD, a combination which appears to be unique among psychiatric conditions studied to date. Elevated concentration of CSF CRH may be related to the persistent irritability and anxiety of our patients. It will prove of interest to characterize the responsivity of CSF CRH to provocative challenge in patients with PTSD.

Keywords: Cerebrospinal fluid (CSF), Corticotropin-Releasing Hormone (CRH) or Corticotropin-Releasing Factor (CRF), Posttraumatic Stress Disorder (PTSD)

Acknowledgments: This work was supported by a VA Central Office Research Funds (Dr. Geracioti).

Return to Stress

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing.

Download a PDF Reader or learn more about PDFs.